Mitochondrial replacement in an iPSC model of Leber's hereditary optic neuropathy

Aging (Albany NY). 2017 Apr;9(4):1341-1350. doi: 10.18632/aging.101231.

Abstract

Cybrid technology was used to replace Leber hereditary optic neuropathy (LHON) causing mitochondrial DNA (mtDNA) mutations from patient-specific fibroblasts with wildtype mtDNA, and mutation-free induced pluripotent stem cells (iPSCs) were generated subsequently. Retinal ganglion cell (RGC) differentiation demonstrates increased cell death in LHON-RGCs and can be rescued in cybrid corrected RGCs.

Keywords: Leber’s hereditary optic neuropathy; cybrid; disease model; induced pluripotent stem cells; retinal ganglion cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis
  • Cell Death
  • Cell Differentiation
  • DNA, Mitochondrial / genetics*
  • DNA, Mitochondrial / metabolism
  • DNA, Mitochondrial / therapeutic use
  • Genetic Therapy / methods*
  • Humans
  • Induced Pluripotent Stem Cells*
  • Microsatellite Repeats
  • Mitochondria / genetics*
  • Optic Atrophy, Hereditary, Leber / therapy*
  • Retinal Ganglion Cells / pathology
  • Stem Cell Transplantation / methods*
  • Superoxides / metabolism

Substances

  • DNA, Mitochondrial
  • Superoxides